DalsnaFinance › IPOs › Corvus Pharmaceuticals Inc › IPO
Corvus Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on March 23, 2016, pricing at $15.00 a share.
| Ticker | CRVS |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | March 23, 2016 |
| Offering price | $15.00 |
| Shares offered | 4,700,000 |
| Total raised | $71M |
Corvus Pharmaceuticals, Inc. sold 4,700,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $70.5 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $71 million total recorded for the deal.
Corvus Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Corvus Pharmaceuticals, Inc.. This page is general information, not investment advice.